Akebia Therapeutics AKBA
NASDAQ AKBA
$0.92 +0.03 (+3.89%)
At close: Aug 20, 2026 · 3:00 PM UTC

Akebia Therapeutics (AKBA) Invested Capital (2018 - 2026)

Akebia Therapeutics (AKBA) posted quarterly Invested Capital of $12.5 million for Q1 2026, down 28.6% quarter-over-quarter from $17.5 million in Q4 2023.

Akebia Therapeutics (AKBA) Invested Capital (2018 - 2026) Analysis & Trends

Akebia Therapeutics (AKBA) has reported Invested Capital for 5 consecutive years, with $12.5 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Invested Capital changed N/A year-over-year to $12.5 million; the TTM figure through Mar 2026 stood at $12.5 million (changed N/A YoY), while the FY2023 annual figure was $17.5 million, down 45.31% from the prior year.
  • Invested Capital fell to $12.5 million in Q1 2026 per AKBA's latest filing, from $17.5 million in the prior quarter.
  • Across five years, Invested Capital topped out at $98.2 million in Q2 2022 and bottomed at $8.0 million in Q3 2023.
  • Historically, Invested Capital has averaged $42.2 million across 3 years, with a median of $24.0 million in 2023.
  • On a YoY basis, Invested Capital climbed as much as 45.31% in 2023 and fell as far as 87.87% in 2023.
  • Akebia Therapeutics' Invested Capital stood at $32.0 million in 2022, then sank by 45.31% to $17.5 million in 2023, then declined by 28.6% to $12.5 million in 2026.
  • Business Quant data shows AKBA's Invested Capital at $12.5 million in Q1 2026, $17.5 million in Q4 2023, and $8.0 million in Q3 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Invested Cap. (Qtr)
1 Haleon 43.91 Bn 42.95 Bn - 9.90 Bn
2 Teva Pharmaceutical Industries 43.15 Bn 39.49 Bn 2.15 Bn 4.50 Bn
3 Zoetis 31.52 Bn 29.84 Bn 1.05 Bn -
4 Takeda Pharmaceutical 28.58 Bn 22.78 Bn 5.10 Bn 3.74 Bn
5 United Therapeutics 22.16 Bn 19.50 Bn 683.80 Mn -
6 Viatris 18.76 Bn 17.87 Bn 1.46 Bn 1.74 Bn
7 Neurocrine Biosciences 15.48 Bn 15.09 Bn 935.80 Mn -
8 Elanco Animal Health 11.69 Bn 11.16 Bn 798.00 Mn 73.00 Mn
9 Dr Reddys Laboratories 10.13 Bn 9.96 Bn - 630.00 Mn
10 Akebia Therapeutics 247.98 Mn 92.43 Mn 38.70 Mn 24.81 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 24.81 Mn
Mar 31, 2026 12.50 Mn
Dec 31, 2023 17.50 Mn
Sep 30, 2023 8.00 Mn
Jun 30, 2023 24.00 Mn
Mar 31, 2023 24.00 Mn
Dec 31, 2022 32.00 Mn
Sep 30, 2022 65.95 Mn
Jun 30, 2022 98.16 Mn
Mar 31, 2022 97.85 Mn
Dec 31, 2021 97.54 Mn
Dec 31, 2018 15.00 Mn